AtkinsRéalis Group (ATRL) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Q1 2026 delivered 18% year-over-year revenue growth to $3.0 billion, with adjusted EBITDA up 18% and adjusted EPS up 27%.
Net income attributable to shareholders increased 34% to $92.8 million, and diluted EPS rose 44% to $0.56.
Robust demand in Nuclear and Engineering Services drove record nuclear revenues and a $20.3 billion backlog.
Strategic acquisitions in Australia and Ireland, and collaboration with NVIDIA on nuclear-powered AI factories, support expansion in high-growth markets.
Maintained strong financial flexibility with $1.1 billion in cash and a net debt/Adjusted EBITDA ratio of -0.4.
Financial highlights
Total revenue reached $2,997.8 million, up 18% year-over-year, with Engineering Services up 12% and Nuclear up 37%.
Segment adjusted EBIT increased 12% to $244.5 million, driven mainly by a 31% rise in the nuclear segment.
Adjusted EBITDA reached $254 million, up 18%, and adjusted diluted EPS rose 27% to $0.80.
Net cash from operating activities more than doubled to $97 million.
$87 million returned to shareholders via buybacks and $39 million via dividends in Q1 2026.
Outlook and guidance
2026 outlook maintained: Nuclear revenue target of ~$2.5 billion, Engineering Services organic growth of 5%-7%, and Segment Adjusted EBITDA margin of 16.5%-17.5%.
Growth in Engineering Services expected to be weighted to the second half of the year, with margins improving sequentially.
Effective tax rate projected at 25%-30% for the full year.
Net cash from operating activities targeted at ~$500 million for 2026.
Latest events from AtkinsRéalis Group
- Record 2024 results, $2.8B asset sale, and strong 2025 growth outlook.ATRL
Q4 202428 Apr 2026 - Record revenue, backlog, and nuclear growth highlight a transformative Q2 with major asset sale.ATRL
Q2 202528 Apr 2026 - Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 20257 Apr 2026 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 20243 Feb 2026 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight Q2 2024.ATRL
Q2 20241 Feb 2026 - Q3 2024 delivered record Nuclear backlog, margin gains, and robust cash flow generation.ATRL
Q3 202414 Jan 2026 - Record backlog and surging Nuclear growth drive raised outlook and strong Q1 2025 results.ATRL
Q1 202519 Nov 2025 - Q3 2025 saw double-digit revenue and EPS growth, record backlog, and raised Nuclear guidance.ATRL
Q3 202513 Nov 2025